Key result
Prolonged sleep latency and protease inhibitors linked to higher arterial stiffness in adolescents with HIV.
Why the study?
Data on arterial stiffness among adolescents with HIV remain limited, particularly in sub-Saharan Africa, where the burden of HIV is high.
What factors are associated with arterial stiffness in adolescents with HIV?
Cross-Sectional (n=416)
What factors are associated with arterial stiffness in adolescents with HIV?
In adolescents with HIV, shorter sleep duration, prolonged sleep latency, and protease inhibitor use are associated with increased arterial stiffness.
Answers are grounded in this paper and cite their sources.
Sleep and PI factors may flag vascular risk in HIV adolescents; leaves open longitudinal studies before any practice implications.
Background Data on arterial stiffness among adolescents with HIV remain limited, particularly in sub-Saharan Africa, where the HIV burden is high.Objective We aimed to assess arterial stiffness among adolescents with HIV, compare these measures with already published measures, and investigate factors associated with arterial stiffness.Methods A cross-sectional study among adolescents with HIV aged 10–17 years was conducted. Carotid-femoral pulse wave velocity (cfPWV) was measured to assess arterial stiffness using the SphygmoCor System (AtCor Medical), defined as a cfPWV ≥ the 90th percentile. Least absolute shrinkage and selection operator (LASSO) regression, followed by multivariable linear regression, was performed to determine associated factors.Results Among 416 adolescents with HIV in Tanzania (mean age 14 years; 53% male), 9.6% (95% CI: 7.0–13.0) had a cfPWV ≥ the 90th percentile. The mean cfPWV in this cohort (4.77 ± 0.65 m/s) was lower than the estimates reported in several cohorts of adolescents with HIV in high-income countries and comparable to that reported in some cohorts in sub-Saharan Africa. Considering age, body mass index, and blood pressure as a priori confounders in multivariable analyses, higher cfPWV was independently associated with shorter sleep duration (β −0.04 per hour; 95%CI: −0.08, 0.0; P = 0.046), prolonged sleep latency ≥ 15 min (β 0.18; 95%CI: 0.05, 0.31; P = 0.006) and current use of a protease inhibitor antiretroviral regimen (β 0.3; 95%CI: 0.00, 0.61; P = 0.049).Conclusion Early screening for arterial stiffness among adolescents with poor sleep behaviours, prior exposure to protease inhibitor-based regimens, and traditional CVD risk factors such as high BMI and blood pressure may provide an opportunity for early intervention through targeted lifestyle changes.
No takes yet. Share an insight, caveat, or question.
Masoza et al. (2026) conducted a cross-sectional in HIV (n=416). Poor sleep behaviors and protease inhibitor use vs. Normal sleep behaviors and other antiretroviral regimens was evaluated on Carotid-femoral pulse wave velocity (cfPWV) (β 0.18, 95% CI 0.05-0.31, p=0.006). Prolonged sleep latency and protease inhibitor use were independently associated with higher arterial stiffness in adolescents with HIV.
Synapse has enriched 10 related papers. Consider them for comparative context: